Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07813260) titled 'Screening for Urological Malignancies Using a Urine Exfoliated Cell Fluorescence Assay in a Hematuria Population' on Sept. 2.

Study Type: Observational

Primary Sponsor: Ruijin Hospital

Condition: UTUC UC (Urothelial Cancer)

Recruitment Status: Recruiting

Date of First Enrollment: April 1, 2026

Target Sample Size: 170

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07813260

Disclaimer: Curated by HT Syndication....